4-bromo-1-isopropyl-3-methyl-1H-pyrazole, 95.0%, 1g

4-Acetyl-2-cyanopyridine, 98%, 250mg

Heptadecan-9-yl 8-((2-hydroxyethyl)amino)octanoate, 98%, 250mg

3-NITRO-1H-PYRAZOLO[3,4-B]PYRIDIN, 97%, 500mg

Bidón tipo 2213, sin conexión para llave de paso, 20 l, 1 pieza

(E)-Methyl 3-(3,5-difluoro-4-formylphenyl)acrylate, 97.0%, 25g

Methyl levulinate, 98%, 25g

5-Amino-2-azepan-1-ylbenzonitrile hydrochloride, 95.0%, 1g

(R)-METHYL 2-AMINO-3-(TERT-BUTOXYCARBONYLAMINO)-3-METHYLBUTANOATE, 95.0%, 2g

4-METHYLPYRROLIDINE-3-CARBOXYLIC ACID, 95%, 250mg

[5-(4-Fluoro-phenyl)-[1,2,4]oxadiazol-3-yl]-acetic acid ethyl ester, 95.0%, 500mg

3-Amino-1-methyl-1H-pyrazole-5-carbonitrile, 95.0%, 1g

5-(2-Chloroacetyl)-4-(trifluoromethyl)-2,3,4,5-tetrahydro-1h-1,5-benzodiazepin-2-one, 95%, 250mg